COVID-19

Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.

A booster vaccine for COVID-19 increased the concentration of antibodies in older patients more than younger patients.

Long COVID can impact quality of life, with some symptoms lasting for 1 year before the patient recovers to baseline.

Cancer screening rates were still below the expected rates of return in both 2021 and 2022.

Single nasal swab test can determine whether a patient has COVID-19, influenza, respiratory syncytial virus, or a combination of these viruses in as little as 2 hours.

IQVIA report states that appropriate reimbursement for all health care professionals who provide immunization services would encourage their ongoing provision of vaccines.

Rapid antigen tests, which can identify infected individuals before they present symptoms, are considered a promising means of reducing the spread of COVID-19.

COVID-19 vaccines are known to have one of the most complex schedules that the average pharmacist has ever had to manage for a vaccine directed towards a single preventable disease.

The efficacy and adverse effects associated with COVID-19 vaccines is a leading cause of hesitancy in parents, according to a new study.

The test, called VirSNiP SARS-CoV-2 Spike F486P, is for research use only and specifically targets the unique mutation F486P found within the XBB.1.5 Omicron sub-variant.

Mortality was highest among Asian, Black, and Hispanic populations, American Heart Association’s 2023 Statistical Update shows.

Increasing efforts have focused on treating COVID-19 among patients in rural areas, who can take advantage of traditional medicines.

Respiratory syntactical virus burdens quality of life and can lead to long-term health outcomes.

Multisystem inflammatory syndrome typically presents approximately 1 month after a COVID infection, occasionally resulting in cardiac complications in previously healthy children.

Individuals with the virus had an 81 times higher risk of dying in the first 3 weeks of infection, and that remained 5 times higher for up to 18 months, analysis shows.

Research showed that 600 hospital beds filled with patients with severe illness would be enough to reimplement (mask mandates to stop the spread of infection.

The therapeutic option is demonstrating favorable results for patients, despite the evolving nature of the SARS-CoV-2 virus.

Data from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.

Viral vector vaccines and a booster can protect maternal women against the Omicron variant of COVID-19, but the mRNA vaccine with a booster dose appears to offer the best protection.

Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?

The new strategy would propose annual COVID-19 vaccines, much like annual flu shots.

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Educating patients, posting on social media, and countering misinformation are critical strategies.

18F-FDG PET/CT detects approximately 73% of tumor lesions, while 68Ga-FAPI finds approximately 94%.

Older patients received cancer treatment less frequently during the pandemic, as did patients covered by Medicaid.

Analysis indicates 4 peptides had significant or nearly significant seropositivity, all of which were associated with membrane and spike proteins of SARS-COVID-2.

COVID-19 infection was significantly associated with increased risks of several conditions, including loss of smell and taste, concentration, and memory impairment.

Recommendations vary based on age, first vaccination received, and time since the last dose.

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

The risk of severe COVID-19 continues to outweigh the rare risk of post-vaccination myocarditis.